difficult to determine the best dose for patients, who must be frequently monitored. In fact, several drugmakers, including Johnson & Johnson and Bayer AG, are also seeking new alternatives to warfarin. Atritech's expandable device ranges from the size...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to US FDA staff cites issues with Atritech device data
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account